Technology
Health
Biotechnology

Natera

$26.18
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.08 (0.31%) Today
$0.00 (0.00%) As of 4:27 PM EDT after-hours

Why Robinhood?

You can buy or sell Natera and other stocks, options, ETFs, and crypto commission-free!

About NTRA

Natera, Inc. engages in the discovery, development, and commercialization of genetic testing services. It offers Panorama Non-Invasive Prenatal Test, Horizon Carrier Screening, Spectrum Pre-implantation Genetic Screening and Spectrum Pre-implantation Genetic Diagnosis, Anora Products of Conception and Non-Invasive Paternity Testing. Read More The company was founded by Matthew Rabinowitz and Jonathan Sheena in November 2003 and is headquartered in San Carlos, CA.

Employees
975
Headquarters
San Carlos, California
Founded
2003
Market Cap
1.65B
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
373.13K
High Today
$26.43
Low Today
$25.29
Open Price
$26.26
Volume
368.19K
52 Week High
$29.62
52 Week Low
$11.08

Collections

Technology
Health
Biotechnology
2015 IPO
US
North America

NTRA News

Yahoo FinanceJun 24

New ProActive™ Study From Natera Will Test for Rejection in 3,000 Kidney Transplant Recipients

139

NTRA Earnings

-$0.85
-$0.72
-$0.60
-$0.47
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 7, After Hours

More NTRA News

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.